Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gutman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|June 14, 2002
Regulatory issues in tumor marker developmentSteven Gutman
Drug Discovery Today|August 30, 2003
Decision making in pharmacogenomic diagnosis: is there anything new under the sun?Steven Gutman, David Feigal
Archives of Pathology & Laboratory Medicine|April 24, 2003
Lexicon for laboratories--scaling the Tower of BabelSteven Gutman, Donna Meyer
Pharmacogenomics|December 23, 2006
Search for shortcuts on the critical path to market: US FDA perspectives from the diagnostic sideSteven Gutman, Joseph Hackett
Nature Reviews. Cancer|June 24, 2006
The US Food and Drug Administration perspective on cancer biomarker developmentSteven Gutman, Larry G Kessler
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2003
Standard reference material for Her2 testing: report of a National Institute of Standards and Technology-sponsored Consensus WorkshopM Elizabeth H Hammond, Peter Barker, Sheila Taube, et al.
The Journal of Urology|April 3, 2013
Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancerLinda A Bradley, Glenn E Palomaki, Steven Gutman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Translational crossroads for biomarkersRobert C Bast, Hans Lilja, Nicole Urban, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|June 14, 2002
Regulatory issues in tumor marker developmentSteven Gutman
Drug Discovery Today|August 30, 2003
Decision making in pharmacogenomic diagnosis: is there anything new under the sun?Steven Gutman, David Feigal
Archives of Pathology & Laboratory Medicine|April 24, 2003
Lexicon for laboratories--scaling the Tower of BabelSteven Gutman, Donna Meyer
Pharmacogenomics|December 23, 2006
Search for shortcuts on the critical path to market: US FDA perspectives from the diagnostic sideSteven Gutman, Joseph Hackett
Nature Reviews. Cancer|June 24, 2006
The US Food and Drug Administration perspective on cancer biomarker developmentSteven Gutman, Larry G Kessler
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2003
Standard reference material for Her2 testing: report of a National Institute of Standards and Technology-sponsored Consensus WorkshopM Elizabeth H Hammond, Peter Barker, Sheila Taube, et al.
The Journal of Urology|April 3, 2013
Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancerLinda A Bradley, Glenn E Palomaki, Steven Gutman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Translational crossroads for biomarkersRobert C Bast, Hans Lilja, Nicole Urban, et al.
Pageof 1